One-year efficacy and safety of the iron-based phosphate binder sucroferric oxyhydroxide in patients on peritoneal dialysis
Nephrology Dialysis Transplantation Nov 17, 2017
Floege J, et al. - The efficacy, as well as tolerability of sucroferric oxyhydroxide and sevelamer in the peritoneal dialysis (PD) patient population, were investigated in this subanalysis. In this patient population, sucroferric oxyhydroxide afforded a relatively low pill burden and a high rate of adherence but was noninferior to sevelamer for controlling serum phosphorus.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries